News
As long as you’re managing your asthma correctly, fitness is still on the table. Fact: Inhalers are essential, safe and ...
The U.S. Food and Drug Administration has approved British drugmaker GSK's asthma drug to treat some patients with a chronic ...
13d
MedPage Today on MSNFDA Approves Mepolizumab for COPDMepolizumab has had a bumpy road to arriving at its indication in COPD. An FDA advisory committee in 2018 declined to ...
A high-tech device that can monitor medication use and compliance has been cleared by the FDA for use with AstraZeneca’s Airsupra and Breztri inhalers ... or prevention of asthma symptoms ...
New research reveals critical controversies in preschool asthma management including drug efficacy, diagnosis, and the role of care teams, calling for a personalized treatment approach.
AstraZeneca (AZ) has shared positive results from a phase 3b study of its anti-inflammatory reliever rescue therapy Airsupra ...
Inhaled corticosteroids (ICS ... Therefore, there has been some concern that the use of ICS as long-term asthma maintenance therapy in children could have a detrimental effect on bone mineral ...
Nucula’s new indication is as an add-on therapy for patients with COPD who also have an elevated blood eosinophil count.
GSK plc (LSE/NYSE: GSK) today announced that the US Food and Drug Administration (FDA) has approved Nucala (mepolizumab) as an add-on maintenance treatment for adult patients with inadequately ...
She testified she had an asthma attack at an airport in Atlanta ... adding that her daily maintenance inhaler was not initially provided to her. Secretary of State Marco Rubio said last week ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results